TherapeuticsMD, Inc.
TXMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $5 | $4 | $38 | $65 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $4 | $3 | $0 | $36 |
| Inventory | $0 | $0 | $0 | $8 |
| Other Curr. Assets | $1 | $4 | $16 | $8 |
| Total Curr. Assets | $10 | $12 | $55 | $119 |
| Property Plant & Equip (Net) | $6 | $7 | $8 | $9 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $4 | $6 | $7 | $7 |
| Long-Term Investments | $16 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $19 | $21 | $34 |
| Total NC Assets | $29 | $32 | $35 | $50 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $39 | $43 | $90 | $169 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $2 | $3 |
| Short-Term Debt | $2 | $0 | $0 | $188 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3 | $4 | $31 | $48 |
| Total Curr. Liab. | $5 | $7 | $47 | $253 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $1 | $2 |
| Total NC Liab. | $6 | $7 | $8 | $10 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $6 | $8 | $9 | $9 |
| Total Liabilities | $11 | $14 | $55 | $263 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$952 | -$950 | -$939 | -$1,051 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $27 | $29 | $35 | -$94 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $39 | $43 | $90 | $169 |
| Net Debt | -$3 | -$4 | -$38 | $123 |